Medical research in Australia: A WEHI-led study in Cell found a 14-protein “blood signature” that can flag lung cancer risk more than five years early, including in non-smokers, pointing to earlier prevention. Biotech at EULAR: Cullinan Therapeutics says early Phase 1 data for its CD19xCD3 T cell engager CLN-978 showed clinical benefit and deep, dose-dependent B cell depletion in refractory lupus and rheumatoid arthritis. Cyber and data security: A lawsuit claims IBM covered up major breaches, including alleged issues tied to APT10, while Australia-focused debate continues over how platforms should be held to account. Rail tech for the Olympics: Alstom won a €69m contract to install ETCS Level 2 digital signalling with 5G radio on Brisbane’s Sunshine Coast line, with local apprenticeships planned. Transport and safety tech: Cricket’s ICC trial will allow pink balls during bad-light stoppages in Tests, though it won’t be ready for the first match at Lord’s. Energy and electrification: Australia’s home battery program delivered 10.7GWh to the grid, as EV uptake accelerates and demand patterns get more dynamic. Policy and education: Australia’s “reading wars” are shifting into a new fight over evidence-based teaching methods across subjects. Health risk and regulation: Experts urge governments to ban the frog-poison “Kambo” detox drug after repeated reports of serious harm and deaths.